|
|
 |
|
| News Release |
|
|
Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 2002 Release |
|
| December 20, 2002 | |
Notice Concerning Subsidiary Dissolution
| |
| December 11, 2002 | |
Eisai Launches SKAINAR COOL FOR RHINITIS and
SKAINAR SPRAY FOR RHINITIS for Allergic and Acute Rhinitis
| |
| November 14, 2002 | |
ACIPHEX , Proton Pump Inhibitor, First Seven-Day Treatment of H.pylori Infection Approved by FDA
| |
| November 13, 2002 | |
Eisai transfers Veterinary and Livestock Feed Products Business to Meiji Seika
| |
| November 5, 2002 | |
Eisai Submits Vascular Dementia Marketing Authorization Application for ARICEPT in the U.K.
| |
| October 24, 2002 | |
Neurogenetics, Inc. Extends Agreement With Eisai Co., Ltd.
| |
| October 17, 2002 | |
Eisai Launches DENTAKE DENTAL RINSE and DENTAKE MEDICATED TOOTH PASTE for Prevention against Periodontal Diseases
| |
| October 10, 2002 | |
Environmental Study Results of Eisai Site in Funado, Itabashi-ku
| |
| October 4, 2002 | |
Eisai Launches SACLON FRESH Drink Refreshing Relief from Upset Stomach
| |
| October 4, 2002 | |
Eisai Launches BREATHE RIGHT KIDS TYPE Nasal Strips for Children of Age 5-12
| |
| September 4, 2002 | |
Eisai Submits sNDA for ARICEPT for Treatment of Vascular Dementia (VaD)
| |
| August 20, 2002 | |
Notice Concerning Acquisition of the Company's Own Shares in the Market
| |
| August 20, 2002 | |
Eisai Launches JUVELUXL For Relief of Hot and Cold Flashes Associated with Menopause
| |
| July 25, 2002 | |
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd., to Promote a Pfizer Product
| |
| July 2, 2002 | |
Eisai Launches TRAVELMIN FAMILY
- A Motion Sickness Medication That Dissolves Quickly In The Mouth -
| |
| July 1, 2002 | |
Notice Concerning Stock Options Including the Amount to Be Paid for the Exercise of Stock Options
| |
| June 27, 2002 | |
Notice of Allotment of Stock Options
| |
| May 14, 2002 | |
Notice Concerning Acquisition of the Company's Own Shares in the Market
| |
| May 14, 2002 | |
Notice on Providing Stock Options in the Form of New Stock Issuance
| |
| May 14, 2002 | |
Eisai Establishes Clinical Research Subsidiary in the United States
| |
| April 17, 2002 | |
Vascular Dementia Phase III Clinical Trial Results for ARICEPT , an ALZHEIMER'S Disease Treatment, Announced at an Academic Conference
| |
| March 26, 2002 | |
Eisai Announces the Merger of Six Japan-based Subsidiaries
| |
| March 20, 2002 | |
Aventis Pharma Ltd. and Eisai Co., Ltd. Announce Copromotion Agreement for the Osteoporosis Therapeutic Agent, ACTONEL 2.5 mg
| |
| February 25, 2002 | |
Notice of Acquisition Completion of the Company's Own Shares through ToSTNeT-2
| |
| February 22, 2002 | |
Notice Concerning Acquisition of the Company's Own Shares in the Market
| |
| February 22, 2002 | |
Notice of Acquisition of the Company's Own Shares through ToSTNeT-2
| |
| February 22, 2002 | |
Notice of Revision of Forecast Year End Dividend For Fiscal Year Period (90th Company Fiscal Period) Ending March 2002
| |
| February 21, 2002 | |
Eisai S.A. in France Acquires All Shares of BIODIM S.A.S.
| |
| February 15, 2002 | |
ACIPHEX Receives Approval for the Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD) in the U.S.
| |
| January 25, 2002 | |
Vascular Dementia Phase III Clinical Trial Results for Aricept, an Alzheimer's Disease Treatment, Announced at an Academic Conference
| |
| January 16, 2002 | |
Eisai Files Application for a New Indication for ACIPHEX in the U.S. For H. Pylori Eradication
| |
| January 7, 2002 | |
Eisai Files Application for Indication Expansion in Japan for PARIET | |
| | | |
|
|
|
